These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3391345)

  • 1. Demonstration of altered antithrombin III activity due to nonenzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients.
    Villanueva GB; Allen N
    Diabetes; 1988 Aug; 37(8):1103-7. PubMed ID: 3391345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes.
    Brownlee M; Vlassara H; Cerami A
    Diabetes; 1984 Jun; 33(6):532-5. PubMed ID: 6724150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate promotes glycation of antithrombin III which interferes with heparin binding.
    Hall PK; Roberts RC
    Biochim Biophys Acta; 1989 Dec; 993(2-3):217-23. PubMed ID: 2597694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
    Griffith MJ
    J Biol Chem; 1982 Dec; 257(23):13899-302. PubMed ID: 7142182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity.
    Ceriello A; Marchi E; Barbanti M; Milani MR; Giugliano D; Quatraro A; Lefebvre P
    Diabetologia; 1990 Apr; 33(4):205-7. PubMed ID: 2347433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.
    Nesheim ME
    J Biol Chem; 1983 Dec; 258(23):14708-17. PubMed ID: 6643505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism.
    Preissner KT; Delvos U; Müller-Berghaus G
    Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
    Speight MO; Griffith MJ
    Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA; Salem HH
    Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III.
    Hoylaerts M; Owen WG; Collen D
    J Biol Chem; 1984 May; 259(9):5670-7. PubMed ID: 6715365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heparin on thrombin inactivation by antithrombin-III.
    Machovich R; Arányi P
    Biochem J; 1978 Sep; 173(3):869-75. PubMed ID: 708377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions.
    Migonney V; Fougnot C; Jozefowicz M
    Biomaterials; 1988 Sep; 9(5):413-8. PubMed ID: 3224126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.
    Hall P; Tryon E; Nikolai TF; Roberts RC
    Clin Chim Acta; 1986 Oct; 160(1):55-62. PubMed ID: 2429788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.